financetom
Business
financetom
/
Business
/
KIMS files draft red herring prospectus with SEBI for Rs 700 cr IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KIMS files draft red herring prospectus with SEBI for Rs 700 cr IPO
Mar 4, 2021 3:23 AM

Krishna Institute of Medical Sciences Ltd (KIMS) has filed a draft red herring prospectus with capital markets regulator Securities and Exchange Board of India (SEBI) for a Rs 700 crore initial public offering. The IPO consists of a fresh issue of shares for Rs 200 crore and the rest will be a sale of shares by some of the present shareholders.

Share Market Live

NSE

As a part of the offer, an overall 1,39,77,991 equity shares would be offered by General Atlantic Singapore KH Pte Ltd for sale. Apart from this, up to 7,75,933 equity shares would be provided by Bhaskara Rao Bollineni.

Moreover, up to 11,63,899 equity shares would be offered by Rajyasri Bollineni and 3,87,966 equity shares by Bollineni Ramanaiah Memorial Hospitals Pvt Ltd. A part of the IPO would be reserved for eligible employees.

The earnings from the fresh issue will be utilised to repay Rs 150 crore of debt of the company and its subsidiaries. KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana. The multidisciplinary integrated private healthcare services provider was established in 2004 by renowned cardiothoracic surgeon Dr Bhaskar Rao.

With an overall bed capacity of 3,064, it runs nine multi-specialty hospitals under the ‘KIMS Hospitals’ brand. As of December 31, 2020, this includes more than 2,500 operational beds, the DRHP said.

KIMS Hospitals provide a wide range of healthcare services across over 25 specialties and super specialties. This comprises orthopaedics, organ transplantation, renal sciences, cardiac sciences, oncology, neurosciences, gastric sciences, and mother and child care.

Axis Capital Ltd, Credit Suisse Securities (India) Pvt Ltd, Kotak Mahindra Capital Co Ltd and IIFL Securities Ltd have been appointed as book running lead managers to the issue. The equity shares are planned to be listed on the BSE and the NSE.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New Gold Q3 Adjusted Net Income, Revenue Increase
New Gold Q3 Adjusted Net Income, Revenue Increase
Oct 29, 2025
03:49 AM EDT, 10/29/2025 (MT Newswires) -- New Gold ( NGD ) reported Q3 adjusted net income late Tuesday of $0.25 per diluted share, up from $0.08 a year earlier. Analysts polled by FactSet expected $0.18. Revenue for the quarter was $462.5 million, up from $252 million a year earlier. Three analysts surveyed by FactSet expected $419.8 million. Shares of...
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
Oct 29, 2025
ZURICH and NESS ZIONA, Israel, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLS or the Company) and Kadimastem Ltd. (TASE: KDST) (Kadimastem ( KMSTF )) today announced that, following the receipt of Nasdaq's approval for the listing of the Company's common shares and the trading of the Company on the Nasdaq Capital Market after completion of the merger between the Company, NLS...
Archrock Q3 Adjusted Earnings, Revenue Rise
Archrock Q3 Adjusted Earnings, Revenue Rise
Oct 29, 2025
03:55 AM EDT, 10/29/2025 (MT Newswires) -- Archrock ( AROC ) reported Q3 adjusted earnings late Tuesday of $0.42 per diluted share, up from $0.28 a year earlier. Three analysts polled by FactSet expected $0.42. Revenue for the quarter ended Sept. 30 was $382.4 million, up from $292.2 million a year earlier. Analysts surveyed by FactSet expected $378.2 million. ...
Santander books record Q3 profit as strong US unit offsets weaker Brazil
Santander books record Q3 profit as strong US unit offsets weaker Brazil
Oct 29, 2025
By Jesús Aguado MADRID (Reuters) -Spain's Santander bank reported a 7.8% year-on-year rise in its third-quarter net profit, saying a strong performance in its U.S. business offset lower lending income and some weakness in Brazil. The net profit of 3.5 billion euros ($4.08 billion) in the July-September quarter reported by the euro zone's biggest bank came above the 3.39 billion...
Copyright 2023-2025 - www.financetom.com All Rights Reserved